SMS Lifesciences India Profit & Loss Annual

BSE: 540679 | NSE: SMSLIFE | ISIN: INE320X01016 | Sector: Biotechnology & Drugs

1,057.30 +50.30 (5.00%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	305.96	315.56	349.74	265.59
Total Revenue	305.96	315.56	349.74	265.59
Costof Revenue Total	208.79	220.98	252.19	181.94
Gross Profit	97.17	94.58	97.55	83.65
Selling/ General/ Admin Expenses Total	49.27	65.83	63.40	53.47
Depreciation/ Amortization	14.94	10.79	10.01	7.86
Other Operating Expenses Total	16.78	-	-	-
Total Operating Expense	289.78	297.60	325.59	243.28
Operating Income	16.18	17.97	24.15	22.32
Interest Inc( Exp) Net- Non- Op Total	-101.57	-53.47	11.53	-25.58
Other Net	3.83	1.62	-0.43	-0.20
Net Income Before Taxes	9.85	16.59	32.73	19.57
Provisionfor Income Taxes	3.52	5.22	7.43	6.01
Net Income After Taxes	6.33	11.38	25.30	13.56
Minority Interest	2.77	0.09	-0.02	-
Net Income Before Extra Items	9.09	11.46	25.28	13.56
Net Income	9.09	11.46	25.28	13.56
Income Availableto Com Excl Extra Ord	9.09	11.46	25.28	13.56
Income Availableto Com Incl Extra Ord	9.09	11.46	25.28	13.56
Diluted Net Income	9.09	11.46	25.28	13.56
Diluted Weighted Average Shares	0.30	0.30	0.30	0.30
Diluted EPS Excluding Extra Ord Items	30.08	37.92	83.61	44.84
DPS- Common Stock Primary Issue	1.50	1.50	1.50	1.50
Diluted Normalized EPS	30.08	32.58	63.52	44.82
Gain( Loss)on Saleof Assets	-	23.50	78.59	0.11